P/E ratio for Viatris (VTRS)
P/E ratio as of September 2023 (TTM): 6.35
According to Viatris's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 6.35294. At the end of 2021 the company had a P/E ratio of -12.9.
P/E ratio history for Viatris from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -12.9 | |
| 2019 | 670 | 1562.77% |
| 2018 | 40.3 | 24.76% |
| 2017 | 32.3 | -22.96% |
| 2016 | 41.9 | 35.69% |
| 2015 | 30.9 | 36.48% |
| 2014 | 22.6 | |
| 2012 | 17.7 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -5.93 | -193.28% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -0.7227 | -111.38% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.